Latest Uppi News
Feb 22, 2024
AtomVie Global Radiopharma collaborates with RLS and UPPI to strengthen distribution network by CM Staff AtomVie, together with RLS and UPPI will bolster its distribution capabilities and allow life-saving treatments to reach more patients. HAMILTON — AtomVie Global Radiopharma Inc. (AtomVie), a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces strategic collaborations with RLS Radiopharmacies and UPPI LLC. (UPPI), two companies involved in radiopharmacy and logistics. This strategic move is poised to enhance AtomVie’s logistics capabilities within the United States, ensuring the widespread distribution of high-quality radiopharmaceuticals by implementing RLS and UPPI as key partners within AtomVie’s existing U.S. distribution network. AtomVie specializes in the GMP manufacturing and global distribution of radiopharmaceuticals, RLS the only Joint Commission-accredited radiopharmacy network in the U.S., owns and operates 31 radiopharmacies covering more than 80% of the United States population, and UPPI, organized as a Group Purchasing Organization (GPO), brings capabilities in logistics and distribution. Radiopharmaceuticals play a pivotal role in precision medicine solutions, providing treatments for various cancer indications. Recognizing the logistics challenges associated with radiopharmaceuticals, given their short half-lives and the critical importance of timely administration; AtomVie, together with RLS and UPPI will bolster its distribution capabilities and allow life-saving treatments to reach more patients. “Our commitment to transforming patient lives through high-quality radiopharmaceuticals is at the core of this partnership with RLS and UPPI,” commented Bruno Paquin, CEO of AtomVie. He added “These collaborations strengthen our ability to deliver critical radiopharmaceuticals to more locations, ensuring timely access for patients who rely on the products. These partnerships not only meet the current demand but position us for future growth, as we meaningfully expand our manufacturing capacity and add commercial-scale capabilities.” Under the agreements, AtomVie will leverage RLS’s and UPPI’s extensive radiopharmacy network, as the companies aim to swiftly deliver radiopharmaceuticals to healthcare providers. Advertisement RLS CEO Stephen Belcher expressed confidence in the partnership’s impact on patient care, stating, “Radiopharmaceuticals begin to decay very rapidly, and it is critical that they reach patients in a safe and timely manner. That’s why this partnership is so important. We are the last mile experts, and by adding our radiopharmacies to its network, AtomVie can ensure its portfolio of life-enhancing therapeutic and diagnostic radiopharmaceuticals reach the right place at the right time, every time.” Advertisement
Uppi Frequently Asked Questions (FAQ)
Where is Uppi's headquarters?
Uppi's headquarters is located at Suwanee.
What is Uppi's latest funding round?
Uppi's latest funding round is Unattributed.
How much did Uppi raise?
Uppi raised a total of $100K.